GlassScriptPhysician profile
Chunguang Chen
NPI 1093862138
$16,546.28
in general payments reported to CMS, 2019-2025
9 companies · $3,124 in 2025
The $3,124 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $930 · 2020: $991 · 2021: $1,611 · 2022: $92.95 · 2023: $8,315 · 2024: $1,483 · 2025: $3,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,300 · Travel and Lodging: $4,896 · Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,300.00 |
| Travel and Lodging | $4,896.41 |
| Food and Beverage | $1,725.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $10,606.83 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $4,230.39 | 2019-2025 | Triclip, Mitraclip |
| Ancora Heart, INC. | $924.18 | 2023 | Accucinch |
| Irhythm Technologies, INC. | $415.60 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic Vascular, INC. | $140.32 | 2019 | |
| Abiomed | $122.10 | 2023 | Impella |
| Boston Scientific Corporation | $78.67 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $28.19 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chunguang Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.